Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0719.HK Stock Summary
In the News
0719.HK Financial details
Company Rating
Strong Buy
Market Cap
10B
Income
509.72M
Revenue
8.55B
Book val./share
6.6
Cash/share
1.14
Dividend
0.22
Dividend %
3.94%
Employees
6.84K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
6.81
Forward P/E
-
PEG
1.82
P/S
1.21
P/B
0.77
P/C
4.72
P/FCF
37.1
Quick Ratio
0.89
Current Ratio
1.38
Debt / Equity
0.3
LT Debt / Equity
0.17
-
-
EPS (TTM)
0.77
EPS next Y
-
EPS next Q
-
EPS this Y
10.71%
EPS next Y
-
EPS next 5Y
-20.27%
EPS last 5Y
9.16%
Revenue last 5Y
7.58%
Revenue Q/Q
-10.2%
EPS Q/Q
-
-
-
-
-
SMA20
-16.67%
SMA50
-16.67%
SMA100
-16.67%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.1%
Gross Margin
29%
Oper. Margin
7%
Profit Margin
6%
Payout
37%
Shs Outstand
1.86B
Shs Float
1.86B
-
-
-
-
Target Price
-
52W Range
4.8-7.47
52W High
-23.14%
52W Low
+34.5%
RSI
40
Rel Volume
0.56
Avg Volume
1.15M
Volume
651.6K
Perf Week
-2.89%
Perf Month
-0.19%
Perf Quarter
5.7%
Perf Half Y
-3.76%
-
-
-
-
Beta
-0.011
-
-
Volatility
0.1%, 0.1%
Prev Close
1.7%
Price
5.38
Change
1.51%
0719.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.36 | 8.97 | 9.61 | 10.54 | 11.13 | |
Net income per share | 0.4 | 0.48 | 0.52 | 0.56 | 0.61 | |
Operating cash flow per share | 0.55 | 0.56 | 0.67 | 0.42 | 1.12 | |
Free cash flow per share | -0.07 | -0.03 | 0.22 | 0.02 | 0.76 | |
Cash per share | 1.14 | 1.1 | 1.27 | 1.11 | 1.72 | |
Book value per share | 4.32 | 4.75 | 5.16 | 5.57 | 6.12 | |
Tangible book value per share | 3.96 | 4.32 | 4.71 | 5.12 | 5.75 | |
Share holders equity per share | 4.32 | 4.75 | 5.16 | 5.57 | 6.12 | |
Interest debt per share | 2.28 | 2.46 | 1.84 | 1.76 | 2.13 | |
Market cap | 1.99B | 2.13B | 1.87B | 2.36B | 4.85B | |
Enterprise value | 2.57B | 2.92B | 2.1B | 2.66B | 5.08B | |
P/E ratio | 7.93 | 7.11 | 5.74 | 6.78 | 11.8 | |
Price to sales ratio | 0.38 | 0.38 | 0.31 | 0.36 | 0.65 | |
POCF ratio | 5.77 | 6.12 | 4.44 | 9.12 | 6.4 | |
PFCF ratio | -48.07 | -116.86 | 13.33 | 238.84 | 9.45 | |
P/B Ratio | 0.74 | 0.72 | 0.58 | 0.68 | 1.18 | |
PTB ratio | 0.74 | 0.72 | 0.58 | 0.68 | 1.18 | |
EV to sales | 0.49 | 0.52 | 0.35 | 0.41 | 0.68 | |
Enterprise value over EBITDA | 3.51 | 3.39 | 2.33 | 2.84 | 4.84 | |
EV to operating cash flow | 7.47 | 8.39 | 4.99 | 10.27 | 6.7 | |
EV to free cash flow | -62.23 | -160.12 | 14.99 | 269.08 | 9.89 | |
Earnings yield | 0.13 | 0.14 | 0.17 | 0.15 | 0.08 | |
Free cash flow yield | -0.02 | -0.01 | 0.08 | 0 | 0.11 | |
Debt to equity | 0.51 | 0.5 | 0.34 | 0.3 | 0.34 | |
Debt to assets | 0.23 | 0.23 | 0.15 | 0.14 | 0.17 | |
Net debt to EBITDA | 0.8 | 0.92 | 0.26 | 0.32 | 0.21 | |
Current ratio | 1 | 0.98 | 1.13 | 1.1 | 1.09 | |
Interest coverage | 6.18 | 7 | 7.07 | 8.01 | 9.59 | |
Income quality | 1.26 | 1.08 | 1.21 | 0.72 | 1.78 | |
Dividend Yield | 0.05 | 0.05 | 0.07 | 0.06 | 0.03 | |
Payout ratio | 0.36 | 0.39 | 0.39 | 0.43 | 0.4 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Capex to operating cash flow | -1.12 | -1.05 | -0.67 | -0.96 | -0.32 | |
Capex to revenue | -0.07 | -0.07 | -0.05 | -0.04 | -0.03 | |
Capex to depreciation | -1.28 | -1.06 | -0.73 | -0.57 | -0.5 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Graham number | 6.25 | 7.16 | 7.77 | 8.38 | 9.17 | |
ROIC | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 | |
Return on tangible assets | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | |
Graham Net | -2.45 | -2.71 | -3.04 | -2.85 | -2.04 | |
Working capital | -10.88M | -57.13M | 305.83M | 252.08M | 298.47M | |
Tangible asset value | 2.46B | 2.7B | 2.94B | 3.18B | 3.88B | |
Net current asset value | -770.44M | -897.11M | -1.01B | -926.93M | -458.27M | |
Invested capital | 0.51 | 0.5 | 0.34 | 0.3 | 0.34 | |
Average receivables | 524.51M | 525M | 548.68M | 764.92M | 986.3M | |
Average payables | 813.95M | 844.06M | 770.71M | 904.65M | 1.08B | |
Average inventory | 832.47M | 1.04B | 1.13B | 1.08B | 1.12B | |
Days sales outstanding | 38.22 | 32.86 | 36.02 | 52.14 | 50.37 | |
Days payables outstanding | 88.97 | 78.11 | 64.7 | 81.32 | 72.8 | |
Days of inventory on hand | 95.18 | 110.57 | 97.92 | 78.36 | 80.94 | |
Receivables turnover | 9.55 | 11.11 | 10.13 | 7 | 7.25 | |
Payables turnover | 4.1 | 4.67 | 5.64 | 4.49 | 5.01 | |
Inventory turnover | 3.83 | 3.3 | 3.73 | 4.66 | 4.51 | |
ROE | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 | |
Capex per share | -0.62 | -0.59 | -0.45 | -0.4 | -0.36 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.8 | 3.04 | 3.83 | 2.95 | 2.69 | |
Net income per share | 0.16 | 0.17 | 0.22 | 0.17 | 0.18 | |
Operating cash flow per share | 0.16 | 0.17 | 0.22 | 0.3 | 0.08 | |
Free cash flow per share | 0.04 | 0.1 | 0.14 | 0.2 | -0.04 | |
Cash per share | 1.9 | 1.72 | 1.25 | 1.36 | 1.14 | |
Book value per share | 6.22 | 6.12 | 6.27 | 6.28 | 6.6 | |
Tangible book value per share | 5.83 | 5.75 | 5.92 | 5.93 | 6.24 | |
Share holders equity per share | 6.22 | 6.12 | 6.27 | 6.28 | 6.6 | |
Interest debt per share | 2.96 | 2.07 | 1.96 | 1.95 | 2.01 | |
Market cap | 2.22B | 4.85B | 3.71B | 3.78B | 3.46B | |
Enterprise value | 2.88B | 5.08B | 4.18B | 4.13B | 3.99B | |
P/E ratio | 5.59 | 10.3 | 6.11 | 7.99 | 7.08 | |
Price to sales ratio | 1.24 | 2.37 | 1.4 | 1.86 | 1.9 | |
POCF ratio | 22.37 | 41.2 | 24.44 | 18.52 | 61.66 | |
PFCF ratio | 95.43 | 72.62 | 38.91 | 26.91 | -140.76 | |
P/B Ratio | 0.56 | 1.18 | 0.86 | 0.87 | 0.77 | |
PTB ratio | 0.56 | 1.18 | 0.86 | 0.87 | 0.77 | |
EV to sales | 1.61 | 2.48 | 1.58 | 2.03 | 2.19 | |
Enterprise value over EBITDA | 25.61 | 31.05 | 21.3 | 20.28 | 34.02 | |
EV to operating cash flow | 29.06 | 43.11 | 27.56 | 20.27 | 71.14 | |
EV to free cash flow | 123.97 | 75.99 | 43.88 | 29.44 | -162.4 | |
Earnings yield | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 | |
Free cash flow yield | 0.01 | 0.01 | 0.03 | 0.04 | -0.01 | |
Debt to equity | 0.47 | 0.34 | 0.31 | 0.31 | 0.3 | |
Debt to assets | 0.23 | 0.17 | 0.17 | 0.17 | 0.17 | |
Net debt to EBITDA | 5.89 | 1.38 | 2.41 | 1.75 | 4.53 | |
Current ratio | 1.08 | 1.09 | 1.47 | 1.3 | 1.38 | |
Interest coverage | 7.91 | 10.96 | 15.74 | 15.3 | 11.05 | |
Income quality | 1 | 1 | 1 | 1.72 | 0.46 | |
Dividend Yield | 0.05 | 0 | 0 | 0 | 0.04 | |
Payout ratio | 1.09 | 0.19 | 0.08 | 0.08 | 1.18 | |
Sales general and administrative to revenue | 0.13 | -0.07 | 0.05 | -0.02 | 0.15 | |
Research and developement to revenue | 0.05 | 0.04 | 0.04 | 0.06 | 0.06 | |
Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Capex to operating cash flow | -0.77 | -0.43 | -0.37 | -0.31 | -1.44 | |
Capex to revenue | -0.04 | -0.02 | -0.02 | -0.03 | -0.04 | |
Capex to depreciation | 0.32 | -0.1 | 0 | -0.25 | 0.32 | |
Stock based compensation to revenue | -0.01 | 0.02 | 0 | 0.01 | -0.01 | |
Graham number | 4.66 | 4.91 | 5.57 | 4.92 | 5.17 | |
ROIC | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham Net | -2.14 | -2.04 | -1.63 | -1.71 | -1.6 | |
Working capital | 242.62M | 298.47M | 999.42M | 752.97M | 840.68M | |
Tangible asset value | 3.72B | 3.88B | 4.08B | 4.09B | 4.24B | |
Net current asset value | -536.86M | -458.27M | -290.71M | -290.22M | -194.49M | |
Invested capital | 0.47 | 0.34 | 0.31 | 0.31 | 0.3 | |
Average receivables | 1.18B | 1.14B | 1.15B | 1.24B | 1.18B | |
Average payables | 1.21B | 1.16B | 1.09B | 1.12B | 1.06B | |
Average inventory | 1B | 1.09B | 1.09B | 990.13M | 990.78M | |
Days sales outstanding | 62.87 | 45.47 | 43.36 | 53.41 | 57.32 | |
Days payables outstanding | 83.05 | 68.53 | 53.97 | 70.44 | 65.82 | |
Days of inventory on hand | 66.02 | 76.2 | 48.17 | 61.9 | 65.87 | |
Receivables turnover | 1.43 | 1.98 | 2.08 | 1.69 | 1.57 | |
Payables turnover | 1.08 | 1.31 | 1.67 | 1.28 | 1.37 | |
Inventory turnover | 1.36 | 1.18 | 1.87 | 1.45 | 1.37 | |
ROE | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | |
Capex per share | -0.12 | -0.08 | -0.08 | -0.09 | -0.12 |
0719.HK Frequently Asked Questions
What is Shandong Xinhua Pharmaceutical Company Limited stock symbol ?
Shandong Xinhua Pharmaceutical Company Limited is a CN stock and trading under the symbol 0719.HK
What is Shandong Xinhua Pharmaceutical Company Limited stock quote today ?
Shandong Xinhua Pharmaceutical Company Limited stock price is $5.38 today.
Is Shandong Xinhua Pharmaceutical Company Limited stock public?
Yes, Shandong Xinhua Pharmaceutical Company Limited is a publicly traded company.